Is LVTX or QYLD a better dividend investment in 2026?

LVTX currently yields 114.94% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: LVTX offers higher current income.

What is the dividend yield difference between LVTX and QYLD?

LVTX has a forward dividend yield of 114.94% ($2.00/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 103.02 percentage points.

Home › Compare › LVTX vs QYLD

LVTX vs QYLD: Dividend Comparison 2026

LVTX yields 114.94% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 LVTX wins by $7.02M in total portfolio value

INVESTMENT

TIME HORIZON10 years

LVTX

● Live price

114.94%

Share price

$1.74

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$7.05M

Annual income

$2,599,161.52

Full LVTX calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — LVTX vs QYLD

📍 LVTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	LVTX	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, LVTX + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

LVTX pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LVTX

Annual income on $10K today (after 15% tax)

$9,770.11/yr

After 10yr DRIP, annual income (after tax)

$2,209,287.29/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, LVTX beats the other by $2,204,476.88/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LVTX + QYLD for your $10,000?

LVTX: 50%QYLD: 50%

100% QYLD50/50100% LVTX

Portfolio after 10yr

$3.54M

Annual income

$1,302,410.42/yr

Blended yield

36.83%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on LVTX right now

LVTX

Analyst Ratings

Buy

Hold

Consensus: Hold

Price Target

$3.75

+115.5% upside vs current

Range: $1.50 — $6.00

Altman Z

-4.7

Piotroski

1/9

QYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LVTX buys

QYLD buys

No recent congressional trades found for LVTX or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricLVTXQYLD

Forward yield	114.94% ✓	11.92%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$7.05M	$25.4K ✓
Annual income after 10y	$2,599,161.52 ✓	$5,659.31
Total dividends collected	$6.38M	$27.1K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: LVTX vs QYLD ($10,000, DRIP)

Year	LVTX Portfolio	LVTX Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$22,194	$11,494.25	$10,352	$1,192.36	+$11.8K → LVTX
2	$47,590	$23,841.72	$10,830	$1,347.57	+$36.8K → LVTX
3	$98,699	$47,777.67	$11,460	$1,539.07	+$87.2K → LVTX
4	$198,214	$92,606.18	$12,275	$1,777.84	+$185.9K → LVTX
5	$385,900	$173,811.71	$13,323	$2,078.95	+$372.6K → LVTX
6	$729,168	$316,254.64	$14,667	$2,463.34	+$714.5K → LVTX
7	$1,338,687	$558,477.43	$16,396	$2,960.57	+$1.32M → LVTX
8	$2,390,633	$958,237.97	$18,631	$3,612.97	+$2.37M → LVTX
9	$4,157,254	$1,599,276.16	$21,548	$4,482.15	+$4.14M → LVTX
10	$7,047,423	$2,599,161.52	$25,398	$5,659.31	+$7.02M → LVTX

LVTX vs QYLD: Complete Analysis 2026

LVTX — Stock

LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer patients. Its lead clinical-stage candidates are LAVA-051, which is in Phase 1/2a clinical trial for blood cancers, including chronic lymphocytic leukemia, multiple myeloma, and acute myeloid leukemia; and LAVA-1207 that is in Phase 1/2a clinical trial for metastatic castration-resistant prostate cancer. The company is also developing other Gammabody drug candidates, which include LAVA-1223, which targets the epidermal growth factor receptor (EGFR) for the treatment of selected solid tumors, as well as LAVA-1266 and LAVA-1278, which are preclinical candidates for the treatment of various hematologic malignancies. LAVA Therapeutics N.V. has a research collaboration and license agreement with Janssen Biotech, Inc. for the potential discovery and development of multi-specific antibody products that are directed to a specified target in various fields of use. The company was incorporated in 2016 and is headquartered in Utrecht, the Netherlands.

Full LVTX Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this LVTX vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LVTX vs SCHD LVTX vs JEPI LVTX vs O LVTX vs KO LVTX vs MAIN LVTX vs XYLD LVTX vs JEPQ LVTX vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.